IQVIA MedTech NV
The computed 12-month bankruptcy probability of IQVIA MedTech NV is 0.2% (very low). The 2023 annual accounts show equity of €34.15M and a net result of €-3.54M. Equity is growing by ~105.2% per year across the filed fiscal years. Its solvency ranks better than 75% of 155 sector peers (fiscal year 2023). The company has been active since 2005 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €34.15M |
| Net result | €-3.54M |
| Staff (FTE) | 31.6 |
| Better than sector | 75% |
Mixed profile: strong on stability, weaker on profitability.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 65.5% | 37.9% | |
| Net result | €-3.54M | €32k | |
| Equity | €34.15M | €118k | |
| Staff costs | €2.94M | €330k | |
| Employees (FTE) | 31.6 | 4.9 |
Show 14 other metrics
| Fiscal year | 2023 |
|---|---|
| Deposit | volledig |
| Revenue | €5.64M |
| EBITDA | €-5.41M |
| Net profit | €-3.54M |
| Cash flow | €-3.53M |
| Staff costs | €2.94M |
| Income taxes | €-930k |
| Dividends | - |
| Total assets | €52.17M |
| Equity | €34.15M |
| Debt | €18.02M |
| of which ≤ 1y | €17.60M |
| of which > 1y | €0 |
| Working capital | €16.94M |
| Employees (FTE) | 31.6 |
| 2023 | |
|---|---|
| Current ratio | 1.96 |
| Quick ratio | 1.96 |
| Working capital ratio | 32.5% |
| Solvency | 65.5% |
| Debt / equity | 0.53 |
| Long-term debt ratio | 0.00 |
| Interest coverage | - |
| Gross margin | - |
| Net margin | -62.9% |
| ROA | -6.8% |
| ROE | -10.4% |
| EBITDA margin | -95.9% |
| Days sales outstanding | 987d |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (26 line items)
| Line item | Code | 2023 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €52.17M |
| Fixed assets | 21/28 | €17.64M |
| Intangible fixed assets | 21 | €17.64M |
| Tangible fixed assets | 22/27 | €0 |
| Current assets | 29/58 | €34.54M |
| Stocks & contracts in progress | 3 | €0 |
| Amounts receivable within one year | 40/41 | €19.57M |
| Investments | 50/53 | €0 |
| Cash & bank | 54/58 | €5.03M |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €52.17M |
| Equity | 10/15 | €34.15M |
| Contributions / capital | 10/11 | €0 |
| Reserves | 13 | €37.70M |
| Accumulated profits (losses) | 14 | €-3.54M |
| Amounts payable | 17/49 | €18.02M |
| Amounts payable after one year | 17 | €0 |
| Amounts payable within one year | 42/48 | €17.60M |
| Trade debts payable within one year | 44 | €16.78M |
| Income statement | ||
| Turnover | 70 | €5.64M |
| Operating result | 9901 | €-5.42M |
| Financial income | 75 | €2.64M |
| Financial charges | 65 | €1.69M |
| Result before taxes | 9903 | €-4.47M |
| Income taxes | 67/77 | €-930k |
| Net result for the period | 9904 | €-3.54M |
| Result to be appropriated | 9905 | €-3.54M |
-
Clément VanthournhoutDirectorState Gazette act 23101080 (03-08-2023)Current03-08-2023 → present
-
Patrick Van DoorenDirectorState Gazette act 23101080 (03-08-2023)Current03-08-2023 → present
-
Emmanuel VanderhaegenManaging directorState Gazette act 23101080 (03-08-2023)Current01-03-2023 → present
2 events
- 03-08-2023 Appointed· Managing director
- 01-03-2023 Appointed· Director
-
An GoethalsBoard member (delegated authority)State Gazette act 22105689 (05-09-2022)Current05-09-2022 → present
-
Clotilde GhysselinckxBoard member (delegated authority)State Gazette act 22105689 (05-09-2022)Current05-09-2022 → present
-
Evert VerbraakBoard member (delegated authority)State Gazette act 22105689 (05-09-2022)Current05-09-2022 → present
Show 5 more sitting directors
-
Liesbet MentenBoard member (delegated authority)State Gazette act 22105689 (05-09-2022)Current05-09-2022 → present
-
Peter LenoirPermanent vertegenwoordigerState Gazette act 22099091 (17-08-2022)Current17-08-2022 → present
-
Brad ThomasDirectorState Gazette act 22079266 (04-07-2022)Current04-07-2022 → present
-
Richard Stanley Farris Jr.DirectorState Gazette act 21034438 (17-03-2021)Current17-03-2021 → present
-
Frank Jos R. SwaelensDirectorState Gazette act 21006084 (15-01-2021)Current15-01-2021 → present
Historic, not recently confirmed (12)
-
Weikai Christopher FangDirectorState Gazette act 19136722 (15-10-2019)Not recently confirmedlast confirmed in an act from 2019
-
Mees IngridNon executive directorState Gazette act 18087374 (05-06-2018)Not recently confirmedlast confirmed in an act from 2018
-
DE KEMPENEER ThomasDirectorState Gazette act 18050590 (23-03-2018)Not recently confirmedlast confirmed in an act from 2018
3 events
- 15-10-2019 Resigned· Director
- 23-03-2018 Appointed· Director
- 18-12-2017 Appointed· Vaste vertegenwoordiger bestuurder
-
SEGERS BartDirectorState Gazette act 18050590 (23-03-2018)Not recently confirmedlast confirmed in an act from 2018
5 events
- 23-03-2018 Appointed· Director
- 23-03-2018 Appointed· Managing director
- 02-03-2017 Resigned· Director
- 31-03-2016 Resigned· Director
- 31-03-2016 Appointed· Director
-
STEVERLYNCK YouriNon executive bestuurderState Gazette act 18050590 (23-03-2018)Not recently confirmedlast confirmed in an act from 2018
2 events
- 23-03-2018 Appointed· Non executive bestuurder
- 31-03-2016 Appointed· Non executive bestuurder
-
TALEN AaltjeDirectorState Gazette act 18050590 (23-03-2018)Not recently confirmedlast confirmed in an act from 2018
4 events
- 17-12-2020 Resigned· Director
- 23-03-2018 Appointed· Director
- 31-03-2016 Resigned· Director
- 31-03-2016 Appointed· Director
-
WAER ChristophDirectorState Gazette act 18050590 (23-03-2018)Not recently confirmedlast confirmed in an act from 2018
4 events
- 15-10-2019 Resigned· Director
- 23-03-2018 Appointed· Director
- 02-03-2017 Resigned· Director
- 31-03-2016 Appointed· Director
-
Korys Business Services I NVLegal entityDirectorState Gazette act 17177201 (18-12-2017)Not recently confirmedlast confirmed in an act from 2017
-
KORYS MANAGEMENT NVLegal entityDirectorState Gazette act 17033493 (02-03-2017)Not recently confirmedlast confirmed in an act from 2017
-
BOSIERS, MarcDirectorState Gazette act 16045327 (31-03-2016)Not recently confirmedlast confirmed in an act from 2016
5 events
- 18-12-2017 Resigned· Director
- 31-03-2016 Resigned· Director
- 31-03-2016 Appointed· Director
- 03-09-2015 Appointed· B bestuurder
- 11-05-2011 Appointed· Director
-
WIJNS, WilliamNon executive bestuurderState Gazette act 16045327 (31-03-2016)Not recently confirmedlast confirmed in an act from 2016
2 events
- 31-03-2016 Appointed· Non executive bestuurder
- 11-05-2011 Appointed· Director
-
Wyns WilliamC bestuurderState Gazette act 15126031 (03-09-2015)Not recently confirmedlast confirmed in an act from 2015
3 events
- 18-12-2017 Resigned· Director
- 31-03-2016 Resigned· Director
- 03-09-2015 Appointed· C bestuurder
Former directors (8)
-
Wouter TackDirectorState Gazette act 20056830 (12-05-2020)Former12-05-2020 → 03-08-2023
3 events
- 03-08-2023 Resigned· Managing director
- 12-05-2020 Appointed· Director
- 12-05-2020 Appointed· Managing director
-
Frank SwaelerDirectorState Gazette act 23030097 (01-03-2023)Former- → 01-03-2023
-
Richard FarrisDirectorState Gazette act 22079266 (04-07-2022)Former- → 04-07-2022
-
Weikai Christopher FarigDirectorState Gazette act 21034438 (17-03-2021)Former- → 17-03-2021
-
AABLER BVBALegal entityDirectorState Gazette act 17033493 (02-03-2017)Former02-03-2017 → 12-05-2020
2 events
- 12-05-2020 Resigned· Director
- 02-03-2017 Appointed· Director
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| Mazars Bedrijfsrevisoren CVCurrent Statutory auditor |
- | 17-08-2022 → present |
Show 1 earlier auditors
| PricewaterhouseCoopers Bedrijfsrevisoren Statutory auditor succeeded by Mazars Bedrijfsrevisoren CV in 2022 |
- | 03-01-2017 → 17-08-2022 |
| NACE primary | Overige technische testen en toetsen(71209) |
| Legal form | Public limited company(014) |
| Incorporation | 18-05-2005 |
| Status | Active |
| Postal code | 2600 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11003A0291/00C002 | Flanders | 7,531 m² | 1 · 1,120 m² | 21.6 m · 6 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 31 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
03-08-2023 3 directors appointed, 1 resigning
- Emmanuel Vanderhaegen, Gedelegeerd bestuurder
- Clément Vanthournhout, Bestuurder
- Patrick Van Dooren, Bestuurder
- Wouter Tack, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "gedelegeerd bestuurder",
"person": {
"rrn": null,
"name": "Wouter Tack",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "gedelegeerd bestuurder",
"person": {
"rrn": null,
"name": "Emmanuel Vanderhaegen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Cl\u00E9ment Vanthournhout",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Patrick Van Dooren",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "IQVIA MedTech"
}
}01-03-2023 1 director appointed, 1 resigning
- Emmanuel Vanderhaegen, Bestuurder
- Frank Swaeler, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Frank Swaeler",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Emmanuel Vanderhaegen",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "IQVIA MedTech"
}
}05-09-2022 4 directors appointed
- An Goethals, Board member (delegated authority)
- Liesbet Menten, Board member (delegated authority)
- Evert Verbraak, Board member (delegated authority)
- Clotilde Ghysselinckx, Board member (delegated authority)
Technical details
{
"events": [
{
"kind": "director_in",
"role": "board member (delegated authority)",
"person": {
"rrn": null,
"name": "An Goethals",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "board member (delegated authority)",
"person": {
"rrn": null,
"name": "Liesbet Menten",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "board member (delegated authority)",
"person": {
"rrn": null,
"name": "Evert Verbraak",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "board member (delegated authority)",
"person": {
"rrn": null,
"name": "Clotilde Ghysselinckx",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "IQVIA MedTech NV"
}
}17-08-2022 2 directors appointed
- Mazars Bedrijfsrevisoren CV, Commissaris
- Peter Lenoir, Permanent vertegenwoordiger
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Mazars Bedrijfsrevisoren CV",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "permanent vertegenwoordiger",
"person": {
"rrn": null,
"name": "Peter Lenoir",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "IQVIA MedTech NV"
}
}04-07-2022 1 director appointed, 1 resigning
- Brad Thomas, Bestuurder
- Richard Farris, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Richard Farris",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Brad Thomas",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "IQVIA MedTech N.V."
}
}17-03-2021 1 director appointed, 1 resigning
- Richard Stanley Farris Jr., Bestuurder
- Weikai Christopher Farig, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Weikai Christopher Farig",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Richard Stanley Farris Jr.",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "GENAE ASSOCIATES"
}
}15-01-2021 Frank Jos R. Swaelens appointed as director
- Frank Jos R. Swaelens, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Frank Jos R. Swaelens",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "GENAE ASSOCIATES"
}
}14-01-2021 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "IQVIA MedTech NV",
"old": "GENAE ASSOCIATES",
"changed": true
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "GENAE ASSOCIATES"
},
"legal_form_change": {
"new": "naamloze vennootschap",
"old": "naamloze vennootschap",
"changed": false
}
}17-12-2020 Aaltje Talen resigns as director
- Aaltje Talen, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Aaltje Talen",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "GENAE ASSOCIATES"
}
}12-05-2020 2 directors appointed, 1 resigning
- Wouter Tack, Bestuurder
- Wouter Tack, Gedelegeerd bestuurder
- AABLER BVBA, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "AABLER BVBA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Wouter Tack",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "gedelegeerd bestuurder",
"person": {
"rrn": null,
"name": "Wouter Tack",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "GENAE ASSOCIATES"
}
}03-02-2020 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "GENAE ASSOCIATES"
},
"legal_form_change": {
"new": "NV",
"old": "Naamloze vennootschap",
"changed": true
}
}15-10-2019 1 director appointed, 4 resigning
- Weikai Christopher Fang, Bestuurder
- Youi Steverlynck, Bestuurder
- Ingrid Maes, Bestuurder
- Christoph Waer, Bestuurder
- Thomas De Kempeneer, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Youi Steverlynck",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Ingrid Maes",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Christoph Waer",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Thomas De Kempeneer",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Weikai Christopher Fang",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "GENAE ASSOCIATES"
}
}26-09-2019 Transaction in capital or shares
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "GENAE ASSOCIATES"
}
}13-08-2019 Transaction in capital or shares
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "GENAE ASSOCIATES"
}
}06-05-2019 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "proposal",
"notary": {
"name": "Michel Wegge",
"firm_city": null,
"firm_name": null,
"office_city": "Borsbeek",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2019-05-06",
"filing_date": "2005-05-12",
"act_kind_objet": "Neerlegging fusievoorstel"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2019-04-11",
"unanimous": null
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0873.863.003",
"name": "GENAE ASSOCIATES NV",
"role": "acquiring",
"address": "Justitiestraat 6 B, 2018 Antwerpen",
"is_foreign": false,
"legal_form": "NV",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": "0628.773.893",
"name": "Hilbert Paradox NV",
"role": "absorbed",
"address": "Justitiestraat 6B, 2018 Antwerpen",
"is_foreign": false,
"legal_form": "NV",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [
"12:7",
"12:50",
"12:75",
"12:103",
"719",
"720",
"721",
"722",
"723",
"724",
"725",
"726",
"727"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2018-12-31",
"exchange_ratio_text": null,
"new_shares_issued_n": 0,
"real_estate_included": false,
"patrimony_description": "De volledige activa en passiva van Hilbert Paradox NV worden overgenomen door GENAE ASSOCIATES NV. De activiteiten van beide vennootschappen zijn verwant, met name op het gebied van administratieve, technische en bedrijfseconomische dienstverlening. De fusie is fiscaal neutraal.",
"equity_transferred_eur": null,
"accounting_effective_date": "2019-01-01"
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "GENAE ASSOCIATES",
"legal_form": "naamloze vennootschap"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "Michel Wegge",
"person_name": null,
"org_rep_person_name": "Michel Wegge"
},
"summary_narrative": "De raad van bestuur van GENAE ASSOCIATES NV en Hilbert Paradox NV heeft een fusievoorstel neergelegd voor een fusie door overneming, waarbij Hilbert Paradox NV wordt overgenomen door GENAE ASSOCIATES NV. De fusie is gebaseerd op verwante activiteiten en wordt fiscaal neutraal verwezenlijkt. De voorstel is voorzien voor goedkeuring door de buitengewone algemene vergaderingen van beide vennootschappen, met een doelstelling van 31 mei 2019. De boekhoudkundige retroactiviteit van de fusie is vanaf 1 januari 2019.",
"co_filed_documents": [
"fusievoorstel"
],
"detected_real_type": "fusion_proposal",
"referenced_correction": null,
"should_reroute_to_category": null
}05-07-2018 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "completed",
"notary": {
"name": "Michel Wegge",
"firm_city": null,
"firm_name": null,
"office_city": "Borsbeek",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2018-07-05",
"filing_date": "2018-06-26",
"act_kind_objet": "Fusie door overneming"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2018-06-15",
"unanimous": null
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0873.863.003",
"name": "GENAE ASSOCIATES",
"role": "acquiring",
"address": "Justitiestraat 6 B, 2018 Antwerpen",
"is_foreign": false,
"legal_form": "naamloze vennootschap",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": "0894.823.416",
"name": "genae Belgium",
"role": "absorbed",
"address": "Justitiestraat 6 B, 2018 Antwerpen",
"is_foreign": false,
"legal_form": "naamloze vennootschap",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [
"12:7",
"12:50",
"12:75",
"12:103",
"719",
"724",
"727"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": "2018-01-01",
"exchange_ratio_text": null,
"new_shares_issued_n": 0,
"real_estate_included": false,
"patrimony_description": "De gehele activa en passiva van het vermogen van \u0027genae Belgium\u0027 worden overgenomen zonder uitzondering of voorbehoud. Alle handelingen verricht door de overgenomen vennootschap sedert 1 januari 2018 worden boekhoudkundig en fiscaal beschouwd als uitgevoerd voor rekening van de overnemende vennootschap.",
"equity_transferred_eur": null,
"accounting_effective_date": "2018-01-01"
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "GENAE ASSOCIATES",
"legal_form": "naamloze vennootschap"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Kathleen Michiels",
"org_rep_person_name": null
},
"summary_narrative": "Op 15 juni 2018 heeft de buitengewone algemene vergadering van GENAE ASSOCIATES besloten tot fusie door overneming van \u0027genae Belgium\u0027, met zetel te Antwerpen. De fusie is uitgevoerd op basis van het fusievoorstel van 13 april 2018, goedgekeurd door de vergadering. De overgenomen vennootschap is ontbonden zonder vereffening, en haar gehele vermogen is overgenomen door GENAE ASSOCIATES. De mandaatverlening van de bestuurders is be\u00EBindigd in verband met de fusie.",
"co_filed_documents": [
"uitgifte akte"
],
"detected_real_type": "fusion_completed",
"referenced_correction": null,
"should_reroute_to_category": null
}05-06-2018 Mees Ingrid appointed as non executive director
- Mees Ingrid, Non executive director
Technical details
{
"events": [
{
"kind": "director_in",
"role": "non-executive director",
"person": {
"rrn": null,
"name": "Mees Ingrid",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "GENAE ASSOCIATES"
}
}14-05-2018 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": "proposal",
"notary": {
"name": "Michel Wegge",
"firm_city": null,
"firm_name": null,
"office_city": "Borsbeek",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2018-05-14",
"filing_date": "2018-05-02",
"act_kind_objet": "Fusievoorstel"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2018-04-13",
"unanimous": null
},
"conversion": null,
"detected_kind": "merger_absorption",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0873.863.003",
"name": "GENAE ASSOCIATES NV",
"role": "acquiring",
"address": "Justitiestraat 6/ B, 2018 Antwerpen",
"is_foreign": false,
"legal_form": "naamloze vennootschap",
"is_new_company": false,
"jurisdiction_country": "BE"
},
{
"kbo": "0894.823.416",
"name": "GENAE BELGIUM NV",
"role": "absorbed",
"address": "Justitiestraat 6 / B, 2018 Antwerpen",
"is_foreign": false,
"legal_form": "naamloze vennootschap",
"is_new_company": false,
"jurisdiction_country": "BE"
}
],
"exchange_ratio": null,
"legal_articles": [
"719"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": 0,
"real_estate_included": false,
"patrimony_description": "De volledige activiteiten en het gehele patrimoine van GENAE BELGIUM NV worden overgenomen door GENAE ASSOCIATES NV. De activiteiten zijn verwant, wat de fusie fiscaal neutraal maakt.",
"equity_transferred_eur": null,
"accounting_effective_date": "2018-01-01"
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "GENAE ASSOCIATES",
"legal_form": "naamloze vennootschap"
},
"publication_proxy": {
"kind": "org",
"org_kbo": "0873.863.003",
"org_name": "GENAE ASSOCIATES NV",
"person_name": null,
"org_rep_person_name": null
},
"summary_narrative": "Het raad van bestuur van GENAE ASSOCIATES NV heeft op 13 april 2018 een fusievoorstel neergelegd voor de fusie door overneming van haar dochtervennootschap GENAE BELGIUM NV. De fusie is gepland op basis van de overeenkomstige activiteiten van beide vennootschappen, met een boekhoudkundige retroactiviteit vanaf 1 januari 2018. Het voorstel zal worden voorgelegd aan de buitengewone algemene vergadering van beide vennootschappen.",
"co_filed_documents": [
"fusievoorstel"
],
"detected_real_type": "fusion_proposal",
"referenced_correction": null,
"should_reroute_to_category": null
}23-03-2018 6 directors appointed
- TALEN Aaltje, Bestuurder
- SEGERS Bart, Bestuurder
- STEVERLYNCK Youri, Non executive bestuurder
- DE KEMPENEER Thomas, Bestuurder
- WAER Christoph, Bestuurder
- SEGERS Bart, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "TALEN Aaltje",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "SEGERS Bart",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "non-executive bestuurder",
"person": {
"rrn": null,
"name": "STEVERLYNCK Youri",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "DE KEMPENEER Thomas",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "WAER Christoph",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "gedelegeerd bestuurder",
"person": {
"rrn": null,
"name": "SEGERS Bart",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "GENAE ASSOCIATES"
}
}18-12-2017 2 directors appointed, 2 resigning
- Korys Business Services I NV, Bestuurder
- Thomas De Kempeneer, Vaste vertegenwoordiger bestuurder
- Marc Bosiers, Bestuurder
- William Wyns, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marc Bosiers",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "William Wyns",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Korys Business Services I NV",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vaste vertegenwoordiger bestuurder",
"person": {
"rrn": null,
"name": "Thomas De Kempeneer",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "GENAE ASSOCIATES"
}
}30-10-2017 Transaction in capital or shares
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "GENAE ASSOCIATES"
}
}02-03-2017 2 directors appointed, 2 resigning
- AABLER BVBA, Bestuurder
- KORYS MANAGEMENT NV, Bestuurder
- Segers Bart, Bestuurder
- Waer Christoph, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Segers Bart",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Waer Christoph",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "AABLER BVBA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "KORYS MANAGEMENT NV",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "GENAE ASSOCIATES"
}
}03-01-2017 PricewaterhouseCoopers Bedrijfsrevisoren appointed as statutory auditor
- PricewaterhouseCoopers Bedrijfsrevisoren, Commissaris
Technical details
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "PricewaterhouseCoopers Bedrijfsrevisoren",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "GENAE ASSOCIATES"
}
}31-03-2016 Transaction in capital or shares
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "GENAE ASSOCIATES"
}
}03-09-2015 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "GENAE ASSOCIATES"
},
"legal_form_change": {
"new": "naamloze vennootschap",
"old": "naamloze vennootschap",
"changed": false
}
}11-05-2011 2 directors appointed
- Dr. Marc Bosiers, Bestuurder
- Dr. William Wijns, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Dr. Marc Bosiers",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Dr. William Wijns",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0873.863.003",
"name_full": "GENAE ASSOCIATES"
}
}| Legal nameNL | IQVIA MedTech NV |